Restricted Cortical and Amygdaloid Removal of Vesicular Glutamate Transporter 2 in Preadolescent Mice Impacts Dopaminergic Activity and Neuronal Circuitry of Higher Brain Function

被引:45
作者
Wallen-Mackenzie, Asa [1 ]
Nordenankar, Karin [1 ]
Fejgin, Kim [4 ]
Lagerstrom, Malin C. [1 ]
Emilsson, Lina [1 ]
Fredriksson, Robert [1 ]
Wass, Caroline [4 ]
Andersson, Daniel [4 ]
Egecioglu, Emil [5 ]
Andersson, My [5 ]
Strandberg, Joakim [5 ]
Lindhe, Oerjan [6 ]
Schioth, Helgi B. [1 ]
Chergui, Karima [7 ]
Hanse, Eric [5 ]
Langstrom, Bengt [2 ]
Fredriksson, Anders [1 ]
Svensson, Lennart [4 ]
Roman, Erika [3 ]
Kullander, Klas [1 ]
机构
[1] Uppsala Univ, Dept Neurosci, S-75124 Uppsala, Sweden
[2] Uppsala Univ, Dept Biochem & Organ Chem, S-75124 Uppsala, Sweden
[3] Uppsala Univ, Dept Pharmaceut Biosci, S-75124 Uppsala, Sweden
[4] Univ Gothenburg, Dept Pharmacol, S-40530 Gothenburg, Sweden
[5] Univ Gothenburg, Dept Physiol, S-40530 Gothenburg, Sweden
[6] GE Healthcare, Uppsala Imanet, S-75109 Uppsala, Sweden
[7] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden
基金
英国医学研究理事会;
关键词
neuronal network; physiology; CNS; transmitter; behavior; schizophrenia; ANIMAL-MODEL; IN-VIVO; SCHIZOPHRENIA; EXPRESSION; AMPHETAMINE; RECEPTORS; KETAMINE; RELEASE; PATHOPHYSIOLOGY; IDENTIFICATION;
D O I
10.1523/JNEUROSCI.5851-08.2009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A major challenge in neuroscience is to resolve the connection between gene functionality, neuronal circuits, and behavior. Most, if not all, neuronal circuits of the adult brain contain a glutamatergic component, the nature of which has been difficult to assess because of the vast cellular abundance of glutamate. In this study, we wanted to determine the role of a restricted subpopulation of glutamatergic neurons within the forebrain, the Vglut2-expressing neurons, in neuronal circuitry of higher brain function. Vglut2 expression was selectively deleted in the cortex, hippocampus, and amygdala of preadolescent mice, which resulted in increased locomotor activity, altered social dominance and risk assessment, decreased sensorimotor gating, and impaired long-term spatial memory. Presynaptic VGLUT2-positive terminals were lost in the cortex, striatum, nucleus accumbens, and hippocampus, and a downstream effect on dopamine binding site availability in the striatum was evident. A connection between the induced late-onset, chronic reduction of glutamatergic neurotransmission and dopamine signaling within the circuitry was further substantiated by a partial attenuation of the deficits in sensorimotor gating by the dopamine-stabilizing antipsychotic drug aripiprazole and an increased sensitivity to amphetamine. Somewhat surprisingly, given the restricted expression of Vglut2 in regions responsible for higher brain function, our analyses show that VGLUT2-mediated neurotransmission is required for certain aspects of cognitive, emotional, and social behavior. The present study provides support for the existence of a neurocircuitry that connects changes in VGLUT2-mediated neurotransmission to alterations in the dopaminergic system with schizophrenia-like behavioral deficits as a major outcome.
引用
收藏
页码:2238 / 2251
页数:14
相关论文
共 62 条
[1]  
ALLEN RM, 1978, AM J PSYCHIAT, V135, P1081
[2]   Modeling madness in mice: One piece at a time [J].
Arguello, P. Alexander ;
Gogos, Joseph A. .
NEURON, 2006, 52 (01) :179-196
[3]   Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter [J].
Bellocchio, EE ;
Reimer, RJ ;
Fremeau, RT ;
Edwards, RH .
SCIENCE, 2000, 289 (5481) :957-960
[4]   Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method [J].
Breier, A ;
Su, TP ;
Saunders, R ;
Carson, RE ;
Kolachana, BS ;
de Bartolomeis, A ;
Weinberger, DR ;
Weisenfeld, N ;
Malhotra, AK ;
Eckelman, WC ;
Pickar, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2569-2574
[5]   Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors [J].
Burris, KD ;
Molski, TF ;
Xu, C ;
Ryan, E ;
Tottori, K ;
Kikuchi, T ;
Yocca, FD ;
Molinoff, PB .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (01) :381-389
[6]   A glutamatergic deficiency model of schizophrenia [J].
Carlsson, A ;
Hansson, LO ;
Waters, N ;
Carlsson, ML .
BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 :2-6
[7]   Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence [J].
Carlsson, A ;
Waters, N ;
Holm-Waters, S ;
Tedroff, J ;
Nilsson, M ;
Carlsson, ML .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 :237-260
[8]   The role of genetic and early environmental factors in determining apomorphine susceptibility [J].
Ellenbroek, BA ;
Sluyter, F ;
Cools, AR .
PSYCHOPHARMACOLOGY, 2000, 148 (02) :124-131
[10]   MPTP-induced deficits in motor activity: neuroprotective effects of the spintrapping agent, alpha-phenyl-tert-butyl-nitrone (PBN) [J].
Fredriksson, A ;
Eriksson, P ;
Archer, T .
JOURNAL OF NEURAL TRANSMISSION, 1997, 104 (6-7) :579-592